Incretin-Based Therapies and the Risk of Breast Cancer in Women with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
International Journal of Drug Research in Clinics · 2023
DOI: 10.34172/ijdrc.2023.e19 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Drug Research in Clinics, 2023. Verfasst von Mobina Oladghaffari und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
This systematic review and meta-analysis assessed the data from cohort studies that compared treatment with or without incretins and the incidence of breast cancer (BC) due to the current controversies.
Methods
PubMed, Scopus, EMBASE, Cochrane, ProQuest, Ovid, and Google Scholar were searched for relevant studies. A secondary analysis was conducted to compare the effect of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dipeptidyl peptidase-4 inhibitors (DPP-4Is) on BC development.
Results
The meta-analysis of four studies with 58,767 patients and 461,475 controls revealed that incretin-based therapies increase the incidence of BC insignificantly (risk ratio (RR)=1.23, 95% confidence interval (CI)=0.44–3.40; P=0.69). The DPP-4I group significantly reduced the risk of BC compared to the GLP-1RA group (RR=0.43, 95% CI=0.32–0.59; P
Zitieren
APA
Oladghaffari, M., Rahnemayan, S., Tohid, Z., Montazer, M., & Dabiri, F. (2023). Incretin-Based Therapies and the Risk of Breast Cancer in Women with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. International Journal of Drug Research in Clinics. https://doi.org/10.34172/ijdrc.2023.e19
Vancouver
Oladghaffari M, Rahnemayan S, Tohid Z, Montazer M, Dabiri F. Incretin-Based Therapies and the Risk of Breast Cancer in Women with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. International Journal of Drug Research in Clinics. 2023. doi:10.34172/ijdrc.2023.e19
BibTeX
@article{Oladghaffari2023,
author = {Oladghaffari, Mobina and Rahnemayan, Sama and Tohid, Zahra and Montazer, Majid and Dabiri, Farnaz},
title = {Incretin-Based Therapies and the Risk of Breast Cancer in Women with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis},
journal = {International Journal of Drug Research in Clinics},
year = {2023},
doi = {10.34172/ijdrc.2023.e19}
}
EUVIMED